Media Mention

Stacie Aarestad Speaks with BBJ About What's Next for Massachusetts' Biotech IPO Market

July 05, 2023

Co-chair of our Capital Markets practice group, Stacie Aarestad, spoke with Boston Business Journal about what's next for the Massachusetts Biotech IPO market, which has stagnated in 2023 so far. Stacie shared that the biopharmaceutical industry is still in a "hangover" mode due to the COVID-19 pandemic as well as inflation, and stressed the importance of capitalizing on market windows.

Read the full article here. (Subscription required)